The increase of CD8+ T lymphocytes induced by CUR in combination with the rV-neuT vaccine must be emphasized because, as we have reported above, the anti-Neu humoral response may not be effective for the elimination of cancer cells. This evidence concerns the gene ERBB2 and cancer.